What does TB-500 stack well with?

For sourcing / quality / procurement protocols, TB-500 pairs with compounds on complementary pathways: BPC-157, GHK-Cu, Ipamorelin. These pairings are selected because they engage independent receptor systems from TB-500's primary mechanism (Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool), producing additive or synergistic effects rather than receptor competition.

What is the mechanism of action of TB-500?

Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local. For sourcing and quality-control applications specifically, the relevant downstream consequence is the cascade from receptor engagement to systemic effect: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. The sourcing / quality / procurement interpretation focuses on the pathway-level detail rather than on any single high-level summary.

What is the evidence base for TB-500?

TB-500's evidence base sits at preclinical + veterinary clinical (equine). The references on this page summarise 2 primary publications supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The sourcing / quality / procurement interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

How should TB-500 be stored and reconstituted?

Lyophilised TB-500 stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

How long until I see results from TB-500?

Acute effects from TB-500 appear within the first week for downstream physiological adaptation. sourcing and quality-control endpoints accumulate across 4–8 weeks; the typical 8–12 week cycle is calibrated to allow the full response window. Single-week evaluations consistently underestimate the response trajectory.

Home/ Compounds/ TB-500

TB-500

Sourcing Guide

Procurement-quality evaluation of TB-500 centres on six markers: lot-specific COA availability, HPLC purity ≥98%, mass spec confirmation matching 888-1717 Da (depending on form), endotoxin testing for injectable routes, vendor regulatory disclosure, and cold-chain shipping options. Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local.. The QC discipline applies regardless of the application; sourcing standards do not relax for any particular use case.

Sourcing / Quality / Procurement Applications

Vial InspectionVendor ComparisonBAC Water SourcingShelf LifeCOA Review

Key Takeaways

Procurement lens: TB-500 sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 888-1717 Da (depending on form).
Mechanism: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool.
Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days.
Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger).
Sourcing-validated stack partners: BPC-157, GHK-Cu, Ipamorelin.

Sourcing / Quality / Procurement Mechanism

For procurement of TB-500, the relevant QC framework covers analytical purity (HPLC), structural identity (mass spec), microbiological safety (endotoxin), and stoichiometric correctness where applicable. Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. This influences cell migration during repair, angiogenesis, and stem-cell mobilisation. Acts systemically when injected anywhere, unlike many peptides whose effects are local. The subsections below address each QC layer and the vendor-tier landscape.

Reconstitution and storage protocols

TB-500 is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.

Vendor tier comparison and price discipline

Three vendor tiers operate in the TB-500 market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.

COA evaluation and red flags

Acceptable TB-500 certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.

Sourcing / Quality / Procurement Applications

Vial Inspection

Sourcing TB-500 for vial inspection use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.

Mass Spectrometry Verification

Pharmaceutical-grade compounded TB-500 is the lowest-risk sourcing path for mass spectrometry verification use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.

Vendor Comparison

For users targeting vendor comparison, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.

BAC Water Sourcing

Sourcing TB-500 for bac water sourcing use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	2-5 mg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	1-5 mg	4–6 weeks initial cycle
Sourcing Guide focus	SubQ	2-5 mg	1-2x weekly SubQ (loading phase); maintenance lower
Maintenance phase	SubQ	1-5 mg	Ongoing with periodic pauses

Dose timing for TB-500 is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

TB-500 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.

TB-500 + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with TB-500's mechanism in sourcing / quality / procurement protocols.
TB-500 + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with TB-500's mechanism in sourcing / quality / procurement protocols.
TB-500 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with TB-500's mechanism in sourcing / quality / procurement protocols.
TB-500 + Semax: Elevates BDNF and NGF in hippocampus and cortex. Pairs naturally with TB-500's mechanism in sourcing / quality / procurement protocols.

Safety & Regulatory Status

WADA: Banned (S0) FDA: Unapproved Research: Preclinical + veterinary clinical (equine)

Generally well tolerated. Limited human safety data. Avoid in active cancer.

Lens-specific safety considerations for sourcing / quality / procurement use of TB-500: Generally well tolerated. Limited human safety data. Avoid in active cancer. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Thymosin β4 and tissue regeneration

PMID 19737543

Supporting

Thymosin β4 — actin sequestration and repair

PMID 22515427

TB-500 vs Related Peptides

Compound	Profile	Onset	Best For
TB-500	Synthetic thymosin β4 fragment	~2-3 days	Sourcing Guide
BPC-157	Stable gastric pentadecapeptide	~4 hr (oral)	Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling
GHK-Cu	Tripeptide-copper complex	~30 min plasma	A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression
Ipamorelin	Selective GHRP / ghrelin mimetic	~2 hr	The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite

Frequently Asked Questions

What should I check on a TB-500 COA?

Acceptable certificates: lot-specific (not template), HPLC purity ≥98%, mass spec confirmation matching 888-1717(depending on form) Da, endotoxin testing for injectable routes, accredited third-party lab issuance. Template COAs and missing endotoxin data are red flags.

Vendor red flags?

Six markers: (1) no lot-specific COAs available, (2) HPLC purity only, no copper or stoichiometry assay where applicable, (3) no physical address or regulatory disclosure, (4) no cold-chain shipping option, (5) no refund policy for failed-QC lots, (6) therapeutic claims about research material. Multiple flags = walk away.

Storage protocol?

Lyophilised: −20°C for 18–24 months. Reconstituted with bacteriostatic water: 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Cold-chain shipping is preferred for purchases; insulated packaging without active cooling is acceptable for shorter transit windows.

Reconstitution best practices?

Use sterile bacteriostatic water (0.9% benzyl alcohol). Inject the BAC water down the side of the vial, not directly onto the lyophilised powder. Allow gentle dissolution; do not shake vigorously — swirl the vial. Label the reconstituted vial with concentration and date.

What is the standard dosing protocol for TB-500?

Conventional TB-500 dosing is 2-5 mg 1-2x weekly subq (loading phase); maintenance lower via subq/im. For sourcing and quality-control use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

What is the regulatory status of TB-500?

TB-500 regulatory status: Unapproved in the United States; WADA status banned (s0); research level preclinical + veterinary clinical (equine). Clinical access for off-label use is via compounded prescription where permissible. International regulatory status varies by jurisdiction. For sourcing and quality-control use specifically, the regulatory profile shapes which monitoring and supervision approaches are required.

Clinical Protocol

Start a TB-500 Protocol

Alukard provides GMP-certified physician-supervised sourcing with GMP-certified TB-500 and Pharmaceutical-grade compounds with full COA documentation.

Get Protocol

Quick Facts

Molecular weight: 888-1717 Da (depending on form)
Sequence length: 17 aa
Half-life: ~2-3 days
WADA: Banned (S0)
FDA: Unapproved
Research: Preclinical + veterinary clinical (equine)

Stack Partners

BPC-157

GHK-Cu

Ipamorelin

Semax

Research Note

All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for TB-500 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

GMP-certified physician-supervised sourcing

Start Your Sourcing / Quality / Procurement Protocol for TB-500

Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised